Morgan Stanley »

Mineralys Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Mineralys Therapeutics (MLYS) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Mineralys Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mineralys Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mineralys Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $8.0M 588k 13.53
2024-12-31 $7.3M 589k 12.31
2024-09-30 $6.2M 516k 12.11
2024-06-30 $5.5M 472k 11.70
2024-03-31 $6.7M 522k 12.91
2023-12-31 $4.6M 536k 8.60
2023-09-30 $1.3M 135k 9.51
2023-06-30 $855k 50k 17.05